Letter to the Editor: "Our Response to COVID-19 as Endocrinologists and Diabetologists"

Leandro Kasuki^{1

2

3}, Mônica R Gadelha^{1

2

4}

Affiliations

¹ Neuroendocrinology Research Center/Endocrinology Division - Medical School and Hospital Universitário Clementino Fraga Filho - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
² Neuroendocrinology Division - Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil.
³ Endocrinology Division - Hospital Federal de Bonsucesso, Rio de Janeiro Brazil.
⁴ Neuropatology and Molecular Genetics Laboratory - Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil.

Comment

Leandro Kasuki et al. J Clin Endocrinol Metab. 2020.

. 2020 Jul 1;105(7):dgaa224.

doi: 10.1210/clinem/dgaa224.

Leandro Kasuki^{1

2

3}, Mônica R Gadelha^{1

2

4}

¹ Neuroendocrinology Research Center/Endocrinology Division - Medical School and Hospital Universitário Clementino Fraga Filho - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
² Neuroendocrinology Division - Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil.
³ Endocrinology Division - Hospital Federal de Bonsucesso, Rio de Janeiro Brazil.
⁴ Neuropatology and Molecular Genetics Laboratory - Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil.

No abstract available

Keywords: COVID-19; SARS-CoV-2; acromegaly; coronavirus; somatostatin receptor ligands.

Comment on

Our Response to COVID-19 as Endocrinologists and Diabetologists.
Kaiser UB, Mirmira RG, Stewart PM. Kaiser UB, et al. J Clin Endocrinol Metab. 2020 May 1;105(5):1299-301. doi: 10.1210/clinem/dgaa148. J Clin Endocrinol Metab. 2020. PMID: 32232480 Free PMC article. No abstract available.